Josh Brumm – Biography

Last update: 24 days ago

Executive profile

Josh was President and Chief Executive Officer at Dyne Therapeutics, and Chief Operating Officer and Chief Financial Officer at Kaleido Biosciences. Josh Brumm joined Forbion in 2024.

Josh Brumm is currently

Create your alert
to follow the career of Josh Brumm.

Education

Josh Brumm graduated from Purdue University and from University of Notre Dame.

They have also studied at Purdue University :

Find more alumni from Purdue University


They have also studied at University of Notre Dame :

Find more alumni from University of Notre Dame

The colleagues of Josh Brumm

Company Colleagues
Homonyms
Industry Colleagues
  • In the Fund industry, Josh Brumm has 30,226 colleagues in 1,666 companies located in 64 countries. 10,679 executive movements have been recorded in the last 12 months. Learn more about Fund.

Report an error
Update the org chart details of Josh Brumm.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard,
and ask for Josh Brumm.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.